Save your place

Sign in to WhoBought

Please try again later.

Pfizer Inc. (PFE) institutional ownership

Latest close $24.91 Jul 30, 2026
Market cap$139.0B 52-week range SectorHealthcare
Funds holding · Q1 2026
2,779
reported PFE position changes
Top owners · Q2 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net bought $406M
1,529 buyers · 1,250 sellers

Pfizer Inc. (PFE) price and institutional activity

Dates

Q1 2026

$6.2B bought by 1529 investors
Fisher Asset Management, LLC$1.4BD. E. Shaw & Co., Inc.$241M +1,527 more
$5.8B sold by 1250 investors
Norges-$2.0BPacer Advisors, Inc.-$431M +1,248 more
Bought Sold Totals per quarter; hover a bar for the names.

Pfizer Inc. (PFE) institutional activity · 2,779

Investor Type Est. change Change Δ Own Date
Norges · Exited −$2.0B
Change −73.5M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −$2.0B −73.5M −100.0% Q1 2026
Fisher Asset Management, LLC Added· Q1 2026 +$1.4B +53.0M +102.0% Q1 2026
Pacer Advisors, Inc. · Exited −$431M
Change −16.2M Δ Own −100.0% Date Q1 2026
Pacer Advisors, Inc. Exited· Q1 2026 −$431M −16.2M −100.0% Q1 2026
D. E. Shaw & Co., Inc. · Added +$241M
Change +9.1M Δ Own +265.0% Date Q1 2026
D. E. Shaw & Co., Inc. Added· Q1 2026 +$241M +9.1M +265.0% Q1 2026
Goldman Sachs Group Inc · Added +$187M
Change +7.0M Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +$187M +7.0M Q1 2026
Acadian Asset Management LLC · Added +$176M
Change +6.6M Date Q1 2026
Acadian Asset Management LLC Added· Q1 2026 +$176M +6.6M Q1 2026
BNP Paribas Financial Markets · Reduced −$176M
Change −6.6M Date Q1 2026
BNP Paribas Financial Markets Reduced· Q1 2026 −$176M −6.6M Q1 2026
Amundi · Reduced −$166M
Change −6.2M Date Q1 2026
Amundi Reduced· Q1 2026 −$166M −6.2M Q1 2026
Janus Henderson Group PLC · Reduced −$148M
Change −5.6M Date Q1 2026
Janus Henderson Group PLC Reduced· Q1 2026 −$148M −5.6M Q1 2026
Bank of New York Mellon Corp · Added +$143M
Change +5.4M Date Q1 2026
Bank of New York Mellon Corp Added· Q1 2026 +$143M +5.4M Q1 2026
BlackRock · Added +$138M
Change +5.2M Date Q1 2026
BlackRock Added· Q1 2026 +$138M +5.2M Q1 2026
Bessemer Group Inc · Added +$134M
Change +5.0M Date Q1 2026
Bessemer Group Inc Added· Q1 2026 +$134M +5.0M Q1 2026
JPMorgan Chase & Co · Added +$121M
Change +4.6M Date Q1 2026
JPMorgan Chase & Co Added· Q1 2026 +$121M +4.6M Q1 2026
Victory Capital Management Inc · Reduced −$114M
Change −4.3M Date Q1 2026
Victory Capital Management Inc Reduced· Q1 2026 −$114M −4.3M Q1 2026
Squarepoint Ops LLC · Reduced −$113M
Change −4.2M Date Q1 2026
Squarepoint Ops LLC Reduced· Q1 2026 −$113M −4.2M Q1 2026
Data through Q1 2026 · filed Jun 11, 2026
15 of 2779

Famous investor activity in Pfizer Inc. (PFE)

Pfizer Inc. (PFE) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Bourla Albert · Director Grant (A) $596
Price $24.82 Qty 24 Owned 773K Trade date Jul 15, 2026 Filed date Jul 16, 2026
Bourla Albert Director Grant (A) $24.82 24 $596 773K Jul 15, 2026 Jul 16, 2026
Bourla Albert · Director Grant (A) $2K
Price $24.25 Qty 84 Owned 773K Trade date Jul 9, 2026 Filed date Jul 13, 2026
Bourla Albert Director Grant (A) $24.25 84 $2K 773K Jul 9, 2026 Jul 13, 2026
Bourla Albert · Director Grant (A) $602
Price $24.08 Qty 25 Owned 773K Trade date Jun 30, 2026 Filed date Jul 1, 2026
Bourla Albert Director Grant (A) $24.08 25 $602 773K Jun 30, 2026 Jul 1, 2026
Buckley Mortimer J. · Director Grant (A) $37K
Price $24.29 Qty 2K Owned 26K Trade date Jun 26, 2026 Filed date Jun 30, 2026
Buckley Mortimer J. Director Grant (A) $24.29 2K $37K 26K Jun 26, 2026 Jun 30, 2026
Echevarria Joseph · Director Grant (A) $46K
Price $24.29 Qty 2K Owned 166K Trade date Jun 26, 2026 Filed date Jun 30, 2026
Echevarria Joseph Director Grant (A) $24.29 2K $46K 166K Jun 26, 2026 Jun 30, 2026
Narayen Shantanu · Director Grant (A) $50K
Price $24.29 Qty 2K Owned 201K Trade date Jun 26, 2026 Filed date Jun 30, 2026
Narayen Shantanu Director Grant (A) $24.29 2K $50K 201K Jun 26, 2026 Jun 30, 2026
Smith James C. · Director Grant (A) $45K
Price $24.29 Qty 2K Owned 183K Trade date Jun 26, 2026 Filed date Jun 30, 2026
Smith James C. Director Grant (A) $24.29 2K $45K 183K Jun 26, 2026 Jun 30, 2026
Quincey James · Director Grant (A) $39K
Price $24.29 Qty 2K Owned 88K Trade date Jun 26, 2026 Filed date Jun 30, 2026
Quincey James Director Grant (A) $24.29 2K $39K 88K Jun 26, 2026 Jun 30, 2026
Taraporevala Cyrus · Director Grant (A) $37K
Price $24.29 Qty 2K Owned 37K Trade date Jun 26, 2026 Filed date Jun 30, 2026
Taraporevala Cyrus Director Grant (A) $24.29 2K $37K 37K Jun 26, 2026 Jun 30, 2026
Bourla Albert · Director Grant (A) $598
Price $26.00 Qty 23 Owned 773K Trade date Jun 15, 2026 Filed date Jun 16, 2026
Bourla Albert Director Grant (A) $26.00 23 $598 773K Jun 15, 2026 Jun 16, 2026
Damico Jennifer B. · Officer Sell −$51K
Price $25.70 Qty −2K Owned 31K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Damico Jennifer B. Officer Sell $25.70 −2K −$51K 31K Jun 9, 2026 Jun 10, 2026
Bourla Albert · Director Grant (A) $602
Price $26.18 Qty 23 Owned 773K Trade date May 29, 2026 Filed date Jun 1, 2026
Bourla Albert Director Grant (A) $26.18 23 $602 773K May 29, 2026 Jun 1, 2026
Bourla Albert · Director Grant (A) $608
Price $25.33 Qty 24 Owned 773K Trade date May 15, 2026 Filed date May 18, 2026
Bourla Albert Director Grant (A) $25.33 24 $608 773K May 15, 2026 May 18, 2026
Bourla Albert · Director Grant (A) $587
Price $26.70 Qty 22 Owned 760K Trade date Apr 30, 2026 Filed date May 4, 2026
Bourla Albert Director Grant (A) $26.70 22 $587 760K Apr 30, 2026 May 4, 2026
Gottlieb Scott · Director Grant (A) $205K
Price $26.67 Qty 8K Owned 57K Trade date Apr 23, 2026 Filed date Apr 27, 2026
Gottlieb Scott Director Grant (A) $26.67 8K $205K 57K Apr 23, 2026 Apr 27, 2026
15 of 91
15 of 91 Sign in to continue to older insider transactions.

Pfizer Inc. (PFE) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Vanguard Capital Management 427.4M
% of shares outstanding 7.5% Filing date May 1, 2026
Vanguard Capital Management 427.4M 7.5% May 1, 2026
1 of 1

Pfizer Inc. (PFE) ownership FAQ

Who owns PFE?

2,779 reporting institutions disclosed PFE position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.